Purpose to review Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children, characterized… Read More
admin
Polymyalgia rheumatica has long been neglected, especially when it comes to pharmaceutical development: but why? In 2025,… Read More
Myasthenia gravis, an immune-mediated neurologic disorder, has for the past century been treated effectively with various immunotherapies,… Read More
Intracranial aneurysms are common, and the risk of rupture is influenced by size, location, morphology, and factors… Read More
In adults with myasthenia gravis, treatment with intravenous inebilizumab, a CD19-specific monoclonal antibody, significantly improved function and… Read More
The field of pulmonary fibrosis has come a long way in the past 25 years, with the… Read More
A 34-year-old man was admitted to the hospital because of left ear pain with hearing loss and… Read More
Purpose of review This review provides a comprehensive perspective on poststreptococcal rheumatic manifestations in pediatric patients by… Read More
Objective To evaluate the timing of uveitis onset in patients with oligoarticular juvenile idiopathic arthritis (oJIA) and… Read More
In this randomized, placebo-controlled trial involving patients with giant-cell arteritis, the oral Janus kinase inhibitor upadacitinib (15… Read More